Baxter Declares Quarterly Dividend

  Baxter Declares Quarterly Dividend

Business Wire

DEERFIELD, Ill. -- July 22, 2014

The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared
a quarterly dividend of $0.52 per Baxter common share. The dividend is payable
on October 1, 2014 to shareholders of record as of September 5, 2014.

In May, Baxter increased its dividend by six percent, bringing the annual
dividend rate to $2.08 per diluted share and maintaining a dividend payout
ratio of approximately 40 percent.

Baxter International Inc., through its subsidiaries, develops, manufactures
and markets products that save and sustain the lives of people with
hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and
other chronic and acute medical conditions. As a global, diversified
healthcare company, Baxter applies a unique combination of expertise in
medical devices, pharmaceuticals and biotechnology to create products that
advance patient care worldwide.

This release includes forward-looking statements concerning Baxter's dividend.
The statements are based on assumptions about many important factors,
including the following, which could cause actual results to differ materially
from those in the forward-looking statements: continued strength in the
company’s financial position, including cash flows; future decisions of the
board of directors of the company to continue payments to shareholders in the
form of a dividend on a quarterly or other basis relative to alternative uses
of funds; the impact of the planned separation of Baxter's biopharmaceutical
and medical products businesses; and other risks identified in the company's
most recent filing on Form 10-K and other SEC filings, all of which are
available on Baxter’s website. Baxter does not undertake to update its
forward-looking statements.


Baxter International Inc.
Media Contact:
Deborah Spak, (224) 948-2349
Investor Contacts:
Mary Kay Ladone, (224) 948-3371
Clare Trachtman, (224) 948-3085
Press spacebar to pause and continue. Press esc to stop.